VIRxSYS Corporation, a privately held company developing vaccines and RNA therapies for serious human diseases such as HIV and cardiovascular diseases, announced results from its prophylactic HIV vaccine (VRX1023) study in Rhesus Macaque monkeys during a presentation today at the 2010 Annual Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco, CA.

Unstarving artists? UVA building boom defies economy The Hook ... Law School alum and founder of New River Pharmaceuticals (maker of the ADHD drug Vyvanse), who was often busy on his Blackberry during the presentation. ...